

Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|8|2|101-119
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.8, Iss.2, 2001-02, pp. : 101-119
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content






Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. :


Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 7, 1999-07 ,pp. :


Recent advances in Factor Xa inhibitors
By Betz Andreas
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 6, 2001-06 ,pp. :